A biotechnologist and molecular biologist whose work integrates AI, metagenomics, and microbiome science to advance precision diagnostics and predictive healthcare. Formerly at The Hospital for Sick Children (SickKids), University of Toronto, he led large-scale transcriptomic/genomics and immunology research focused on respiratory and inflammatory diseases. He is the Founder and CEO of DigiBiomics, developing AI-driven platforms such as LungSense to enable early detection, risk prediction, and preventive respiratory care.
